Pfizer Inc.
US ˙ NYSE ˙ US7170811035

SecurityPFE / Pfizer Inc.
InstitutionCNB Bank
Latest Disclosed Ownership44,385 shares
Latest Disclosed Value $ 1,246,330
CNB Bank ownership in PFE / Pfizer Inc.

On May 6, 2026 - CNB Bank filed a 13F-HR form disclosing ownership of 44,385 shares of Pfizer Inc. (US:PFE) valued at $1,246,331 USD as of March 31, 2026. The entity filed a previous 13F-HR on February 11, 2026 disclosing 44,385 shares of Pfizer Inc.. This represents a change in shares of 0.00% during the quarter. The current value of the position is $1,124,716 USD.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date		 Effective
Date		Form Security Class ID Avg Price
Paid (Est)		 Reported
Shares		 ΔShares ΔShares
(%)		 Reported
Value
(x1000)		 ΔValue
(%)		 Alloc
(%)		 ΔAlloc ΔAlloc (%) Cost Basis
(x1000)		 Unrealized
Gain/Loss
(x1000)
2026-05-06 2026-03-31 13F PFIZER COM 717081103 44,385 0 0.00 1,246 12.76 0.5244
2026-02-11 2025-12-31 13F PFIZER COM 717081103 44,385 -493 -1.10 1,105 -3.32 0.4523
2025-10-30 2025-09-30 13F PFIZER COM 717081103 44,878 5,418 13.73 1,143 19.56 0.4764
2025-07-31 2025-06-30 13F PFIZER COM 717081103 39,460 -1,214 -2.98 957 -7.18 0.4534
2025-04-24 2025-03-31 13F PFIZER COM 717081103 40,674 -2,870 -6.59 1,031 -10.82 0.5217
2025-01-15 2024-12-31 13F Pfizer COM 717081103 43,544 -3,701 -7.83 1,155 -15.51 0.5368
2024-10-18 2024-09-30 13F Pfizer COM 717081103 47,245 -1,714 -3.50 1,367 -0.15 0.6324
2024-08-08 2024-06-30 13F Pfizer COM 717081103 48,959 -4,545 -8.49 1,370 -7.75 0.6590
2024-05-02 2024-03-31 13F Pfizer COM 717081103 53,504 -14,375 -21.18 1,485 -24.05 0.7240
2024-01-31 2023-12-31 13F Pfizer COM 717081103 67,879 -1,079 -1.56 1,954 -14.56 1.0493
2023-11-02 2023-09-30 13F Pfizer COM 717081103 68,958 -472 -0.68 2,287 -10.17 1.3468
2023-08-08 2023-06-30 13F Pfizer COM 717081103 69,430 -1,601 -2.25 2,547 -12.15 1.4980
2023-05-10 2023-03-31 13F Pfizer COM 717081103 71,031 -75 -0.11 2,898 -20.45 1.7638
2023-02-13 2022-12-31 13F Pfizer COM 717081103 71,106 296 0.42 3,644 17.55 2.2781
2022-11-14 2022-09-30 13F Pfizer COM 717081103 70,810 -250 -0.35 3,099 -16.81 2.0967
2022-08-19 2022-06-30 13F/A-1 Pfizer COM 717081103 71,060 2,251 3.27 3,725 4.58 2.4095
2022-08-10 2022-06-30 13F Pfizer COM 717081103 93,999 25,190 4,928 2.0319
2022-04-13 2022-03-31 13F Pfizer COM 717081103 68,809 -724 -1.04 3,562 -13.25 1.9745
2022-01-31 2021-12-31 13F Pfizer COM 717081103 69,533 -1,304 -1.84 4,106 34.76 2.2497
2021-11-02 2021-09-30 13F Pfizer COM 717081103 70,837 1,554 2.24 3,047 12.31 1.8301
2021-07-29 2021-06-30 13F Pfizer COM 717081103 69,283 82 0.12 2,713 8.22 1.6966
2021-05-03 2021-03-31 13F Pfizer COM 717081103 69,201 -1,814 -2.55 2,507 -4.09 1.7344
2021-01-27 2020-12-31 13F Pfizer COM 717081103 71,015 -2,718 -3.69 2,614 -3.40 1.9742
2020-10-26 2020-09-30 13F Pfizer COM 717081103 73,733 1,460 2.02 2,706 14.52 2.2777
2020-07-14 2020-06-30 13F Pfizer COM 717081103 72,273 -309 -0.43 2,363 -0.25 2.0797
2020-05-13 2020-03-31 13F Pfizer COM 717081103 72,582 964 1.35 2,369 -15.57 2.5520
2020-01-27 2019-12-31 13F Pfizer COM 717081103 71,618 2,738 3.98 2,806 13.37 2.3754
2019-11-04 2019-09-30 13F Pfizer COM 717081103 68,880 2,041 3.05 2,475 -14.54 2.2908
2019-08-14 2019-06-30 13F Pfizer COM 717081103 66,839 698 1.06 2,896 3.10 2.4714
2019-04-29 2019-03-31 13F Pfizer COM 717081103 66,141 7,761 13.29 2,809 10.24 1.4467
2019-02-06 2018-12-31 13F Pfizer Inc Com COM 717081103 58,380 -1,433 -2.40 2,548 -3.34 1.6234
2018-11-13 2018-09-30 13F Pfizer Inc Com COM 717081103 59,813 -825 -1.36 2,636 19.82 1.5083
2018-08-14 2018-06-30 13F Pfizer Inc Com COM 717081103 60,638 95 0.16 2,200 2.37 1.2815
2018-05-11 2018-03-31 13F Pfizer Inc Com COM 717081103 60,543 3,763 6.63 2,149 4.47 1.2555
2018-02-20 2017-12-31 13F Pfizer Inc Com COM 717081103 56,780 56,780 2,057 1.2301
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.